Spatially encoded biological assays

• US 10,662,468 B2
• Filed: 10/22/2019
• Issued: 05/26/2020
• Est. Priority Date: 04/05/2010
• Status: Active Grant

• Current Assignee: Prognosys Biosciences Inc.
• Original Assignee: Prognosys Biosciences Inc.
• Inventors: Chee, Mark S.
• Primary Examiner(s): Martinell, James
• Application Number:
  US16/660,234
• Publication Number:
  US 20200048690A1
• Time in Patent Office: 217 Days
• Field of Search: None
• CPC Class Codes: B01L 3/502715 characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
• CPC Class Codes: C12Q 1/6804 Nucleic acid analysis using immunogens immunoassay G01N33/53
• CPC Class Codes: C12Q 1/6809 Methods for determination or identification of nucleic acids involving differential detection
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 1/6841 In situ hybridisation
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2535/122 Massive parallel sequencing
• CPC Class Codes: C12Q 2543/10 the purpose being "in situ" analysis
• CPC Class Codes: C12Q 2563/179 the label being a nucleic acid
• CPC Class Codes: C12Q 2565/515 characterised by the interaction between or sequential use of two or more arrays
• CPC Class Codes: C40B 30/04 by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
• CPC Class Codes: C40B 60/04 Integrated apparatus specially adapted for both screening libraries and identifying library members
• CPC Class Codes: G01N 2458/10 Oligonucleotides as tagging agents for labelling antibodies
• CPC Class Codes: G01N 33/5308 for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
• CPC Class Codes: G01N 33/543 with an insoluble carrier for immobilising immunochemicals
• CPC Class Codes: G01N 33/6845 Methods of identifying protein-protein interactions in protein mixtures

Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

Claims

1. A method for determining the presence or abundance of a nucleic acid at a location in a tissue section comprising:

(a) contacting the tissue section with an array comprising a plurality of features, wherein a feature of the plurality of features comprises a capture agent, wherein the capture agent comprises;

(i) a first sequence that specifically binds the nucleic acid, and

(ii) a second sequence comprising a coding tag, wherein a sequence of the coding tag corresponds to a location of the capture agent on the array;

(b) determining all or a portion of the sequence of the coding tag, or a complement thereof, and all or a portion of the sequence of the nucleic acid specifically bound to the capture agent, or a complement thereof, and using the determined sequences to determine presence or abundance of the nucleic acid at a location in the tissue section.

2. The method of claim 1, wherein the method further comprises, between steps (a) and (b), a step of removing the tissue section from the array.

3. The method of claim 2, wherein the removing step includes the use of an RNase.

4. The method of claim 2, wherein the removing step includes washing the array to remove any nucleic acid(s) not specifically bound to the capture agent.

5. The method of claim 1, wherein the capture agent, when specifically bound to the nucleic acid, can function as a primer.

6. The method of claim 1, wherein the determining step comprises nucleic acid amplification.

7. The method of claim 1, wherein the determining step comprises sequencing all or a portion of the sequence of the coding tag, or a complement thereof, and all or a portion of the sequence of the nucleic acid specifically bound to the capture agent, or a complement thereof.

8. The method of claim 1, wherein the capture agent further comprises one or both of a primer region and an adaptor region.

9. The method of claim 8, wherein one or both of the primer region and the adaptor region comprise(s) a universal nucleotide sequence.

10. The method of claim 1, wherein the nucleic acid is DNA.

11. The method of claim 10, wherein the DNA is genomic DNA.

12. The method of claim 1, wherein the nucleic acid is RNA.

13. The method of claim 12, wherein the RNA is mRNA.

14. The method of claim 13, wherein the determining step includes generation of a cDNA using the capture agent specifically bound to the nucleic acid as a primer.

15. The method of claim 14, wherein the generated cDNA comprises all or a portion of the sequence of the coding tag, and a sequence complementary to all or a portion of the sequence of the nucleic acid.

16. The method of claim 14, wherein the determining step further comprises amplifying the cDNA.

17. The method of claim 1, wherein the feature of the plurality of features comprises a bead, well, or channel.

18. The method of claim 1, wherein the capture agent is immobilized directly or indirectly on a surface of the feature.

19. The method of claim 1, wherein the array comprises a nucleic acid array.

20. The method of claim 1, wherein the array comprises a bead array.

21. The method of claim 1, wherein the tissue section is a fresh frozen tissue section or a formalin-fixed paraffin-embedded (FFPE) tissue section.

22. The method of claim 1, wherein the method further comprises imaging the tissue section contacted with the array.

23. The method of claim 1, wherein the method further comprises generating a map of the presence or abundance of the nucleic acid at location(s) in the tissue section.

24. The method of claim 1, wherein the tissue section comprises tissue from a subject, and the method further comprises performing steps (a) and (b) on additional, serial tissue section(s) obtained from the subject.

25. The method of claim 1, wherein the array comprises greater than 500 features.

26. The method of claim 1, wherein the array comprises greater than 1,000 features.

27. The method of claim 1, wherein the array comprises greater than 10,000 features.

28. The method of claim 1, wherein a feature of the plurality of features comprises greater than 20 capture agents, where each of the greater than 20 capture agents comprises a first sequence that specifically binds to a different nucleic acid and a coding tag that corresponds to a location of the capture agent on the array.

29. The method of claim 1, wherein a feature of the plurality of features comprises greater than 50 capture agents, where each of the greater than 50 capture agents comprises a first sequence that specifically binds to a different nucleic acid and a coding tag that corresponds to a location of the capture agent on the array.

30. The method of claim 1, wherein a feature of the plurality of features comprises greater than 100 capture agents, where each of the greater than 100 capture agents comprises a first sequence that specifically binds to a different nucleic acid and a coding tag that corresponds to a location of the capture agent on the array.